GLENMARK LIFE SCIENCES
|
The Current P/B Ratio of GLENMARK LIFE SCIENCES is 5.54.
Share Price | ₹1,048.9 | Nov 22,2024 |
Market Cap | ₹12,849.0 Cr | |
Book Value | ₹2,321.3 Cr | Mar2024 - Standalone Results |
Price/Book | 5.54x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of GLENMARK LIFE SCIENCES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹12,849.0 Cr] as on Nov 22,2024
(/) Book Value [ ₹2,321.3 Cr] based on Mar2024 - Standalone Results
(=) P/B Ratio [ 5.54x ]
Thus, for GLENMARK LIFE SCIENCES , the investors are currently willing to pay '5.54 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLENMARK LIFE SCIENCES !
The chart below summarizes the trend in P/B Ratio of GLENMARK LIFE SCIENCES over the last five years.
Historical PB (Price/Book ) ratio chart of GLENMARK LIFE SCIENCES
PB Ratio Performance Analysis for GLENMARK LIFE SCIENCES
- GLENMARK LIFE SCIENCES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.82x.
- GLENMARK LIFE SCIENCES 's operated at median p/b ratio of 2.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK LIFE SCIENCES 's p/b ratio peaked in Mar2024 at 4.09x.
- GLENMARK LIFE SCIENCES 's p/b ratio hit its five-year low in Mar2021 of 0x.
How does GLENMARK LIFE SCIENCES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
GLENMARK LIFE SCIENCES | 2,321.26 | 5.54 | 12,849.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.78 | 431,352.0 |
CIPLA LTD | 26,619.90 | 4.51 | 120,035.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.60 | 101,286.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.81 | 95,461.4 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.74 | 159,265.0 |
MANKIND PHARMA LTD | 9,339.84 | 10.95 | 102,231.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.65 | 107,306.0 |
LUPIN LTD | 14,175.80 | 6.66 | 94,430.6 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.38 | 71,069.8 |
ABBOTT INDIA LTD | 3,658.73 | 16.09 | 58,859.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLENMARK LIFE SCIENCES 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.38x |
Max industry PB | 16.09x |
Median industry PB | 6.66x |
Average industry PB | 8.06x |
You may also like the below Video Courses